Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study

Lupus. 2018 Feb;27(2):312-318. doi: 10.1177/0961203317720527. Epub 2017 Jul 12.

Abstract

Background This study aimed to address whether bloodstream infections are a risk factor for the development of severe lupus flares, as well as clinical, immunological and microbiological features of patients with bloodstream infections that develop severe lupus flares. Methods We performed a retrospective cohort study comparing 87 systemic lupus erythematosus (SLE) patients with bloodstream infections and 87 hospitalized SLE patients without bloodstream infections as a comparison group. All patients were followed up for at least 3 months or until one of the primary outcomes was developed (severe SLE flare according to SELENA/SLEDAI score or death). Microbiological features of all bloodstream infections were recorded. The disease status at the end of follow up was registered. Results A total of 23 patients (13.2%) developed a severe flare during follow up; among them, 20 (87%) had an associated episode of bloodstream infection ( p < 0.001). The most frequent flares were renal (43.4%) and severe thrombocytopenia (26%). After multivariate analysis, baseline-independent factors associated with severe SLE flare were bloodstream infection [hazard ratio (HR) 7.3, 95% confidence interval (CI) 2.13-24.95; p = 0.002]. Among patients with bloodstream infections, low C4 levels (HR 2.43, 95% CI 1.04-5.69: p = 0.04) and Streptococcus pneumoniae were associated with severe SLE flare (HR 3.41, 95% CI 1.68-6.91; p = 0.012). Conclusions SLE patients with bloodstream infections, especially due to S. pneumoniae, and low C4 levels, are at higher risk for development of severe SLE flares.

Keywords: Bacteremia; C4; S. pneumoniae; SLE; flare.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Bacteremia / diagnosis
  • Bacterial Infections / blood*
  • Bacterial Infections / complications
  • Cohort Studies
  • Complement C4 / metabolism
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / blood*
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / microbiology*
  • Lupus Nephritis / complications*
  • Lupus Nephritis / epidemiology
  • Male
  • Mexico / epidemiology
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Streptococcus pneumoniae / isolation & purification
  • Symptom Flare Up
  • Thrombocytopenia / complications*
  • Thrombocytopenia / epidemiology

Substances

  • Complement C4